LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹57 Cr | ₹72 Cr | ₹130 Cr | ₹162 Cr | ₹141 Cr |
What is the latest Total Debt ratio of LYKA LABS ?
Year | Total Debt |
---|---|
Mar2024 | ₹57 Cr |
Mar2023 | ₹72 Cr |
Mar2022 | ₹130 Cr |
Mar2021 | ₹162 Cr |
Mar2020 | ₹141 Cr |
How is Total Debt of LYKA LABS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹57 Cr | -21.44 | |
Mar2023 | ₹72 Cr | -44.54 | |
Mar2022 | ₹130 Cr | -19.86 | |
Mar2021 | ₹162 Cr | 14.93 | |
Mar2020 | ₹141 Cr | - |
Compare Total Debt of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹408.9 Cr | -2.7% | -5% | 4.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,614.0 Cr | -2.5% | -4.7% | 11.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,533.0 Cr | -2.7% | -0.7% | 50.4% | Stock Analytics | |
CIPLA | ₹121,439.0 Cr | -1.2% | 0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,076.0 Cr | -2.3% | 8.2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,066.0 Cr | 1.4% | -1.5% | 13.3% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | -2.7% |
-5% |
4.2% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses